Clinical trial discovery
Find Clinical Trials
Search studies by condition, treatment, location, eligibility, or trial identifier.
Showing 1–20 of 25 trials
Active filters
Clinical trials found
Published and searchable clinical trials
Searching for clinical trials...
Recruiting
Registry Platform Hematologic Malignancies (RUBIN) - Extension of Tumor Registry Lymphatic Neoplasms
NCT06043011
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Chronic Disease, +34 more
- Locations
-
- Praxis für Interdisziplinäre Hämatologie und Onkologie Freiburg im Breisgau, Germany
NCT03460977
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Disease Attributes, +23 more
- Locations
-
- Banner-University Medical Center Tucson Tucson, Arizona, United States
- The University of Arizona Cancer Center-North Campus Tucson, Arizona, United States
- The University of Arizona Cancer Center Tucson, Arizona, United States
- Arizona Urology Specialists, PLLC Tucson, Arizona, United States
- Conditions
- Follicular Lymphoma (FL), Hemic and Lymphatic Diseases, Immune System Diseases, +8 more
- Locations
-
- UCSF Fresno /ID# 264712 Fresno, California, United States
- Scripps Mercy Hospital /ID# 265393 San Diego, California, United States
- Sansum Clinic Research /ID# 261596 Santa Barbara, California, United States
- Rocky Mountain Cancer Centers - Boulder /ID# 261203 Boulder, Colorado, United States
NCT05131022
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Chronic Disease, +37 more
- Locations
-
- City of Hope Duarte, California, United States
- University of California, San Francisco San Francisco, California, United States
- Colorado Blood Cancer Institute Denver, Colorado, United States
- Yale Cancer Center New Haven, Connecticut, United States
Recruiting
Dose Determining Study of EXS73565 in Participants With Relapsed or Refractory B-Cell Malignancies
NCT06980116
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Chronic Disease, +38 more
- Locations
-
- LLC ARENSIA Exploratory Medicine Tbilisi, Georgia
- IMSP Institute of Oncology, ARENSIA Exploratory Medicine Chisinau, Moldova
- Hospital Beata Maria Ana Madrid, Spain
- Hospital Fundación Jiménez Diaz Madrid, Spain
Recruiting
Dose Escalation and Dose Expansion Study of MDX2003 in Patients With Different Types of Lymphoma
NCT07249905
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, DLBCL - Diffuse Large B Cell Lymphoma, +28 more
- Locations
-
- Epworth HealthCare Richmond, Victoria, Australia
- Linear Clinical Research Nedlands, Western Australia, Australia
NCT07548697
- Conditions
- B-cell Non Hodgkin Lymphoma (NHL), DLBCL - Diffuse Large B Cell Lymphoma, Dendritic Cell Sarcoma, Interdigitating, +14 more
- Locations
-
- Union Hospital, Tongji Medical College, Huazhong University of Science and Technology Wuhan, Hubei, China
NCT04830137
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Chronic Disease, +36 more
- Locations
-
- City of Hope Duarte, California, United States
- University of California Irvine Orange, California, United States
- University of California San Francisco Medical Center San Francisco, California, United States
- Sarah Cannon Research Institute at Colorado Blood Cancer Institute Denver, Colorado, United States
NCT03869619
- Conditions
- Burkitt Lymphoma, Burkitt Lymphoma (BL)), DNA Virus Infections, +26 more
- Locations
-
- Unité d'Hématologie Clinique, CH D'ARRAS Arras, France
- Service d'Hématologie, CHU Jean Minjoz Besançon, France
- Service d'Onco-radiolothérapie, Polyclinique Bordeaux Nord Aquitaine Bordeaux, France
- Institut Bergonié Bordeaux, France
Enrolling by Invitation
Long-term Study to Evaluate Safety and Persistence of GF-CART01
NCT06985576
- Conditions
- DLBCL - Diffuse Large B Cell Lymphoma, Dendritic Cell Sarcoma, Interdigitating, Follicular Lymphoma (FL), +14 more
- Locations
-
- National Taiwan University Hospital Taipei, Taiwan
Not Yet Recruiting
A Study to Evaluate the Safety and Efficacy of SCTB35 in Combination With Lenalidomide in Patients With Relapsed or Refractory Follicular Lymphoma
NCT07562022
- Conditions
- Follicular Lymphoma (FL), Hemic and Lymphatic Diseases, Immune System Diseases, +8 more
- Locations
-
- Beijing Cancer Hospital Beijing, Beijing Municipality, China
Not Yet Recruiting
Sonrotoclax, Zanubrutinib and Rituximab in Previously Untreated Patients With Follicular Lymphoma
NCT07550855
- Conditions
- Follicular Lymphoma (FL), Hemic and Lymphatic Diseases, Immune System Diseases, +8 more
- Locations
-
- Sun Yat-sen Universitiy Cancer Center Guangzhou, Guangdong, China
- Conditions
- Adult B-cell Acute Lymphoblastic Leukemia, Burkitt Lymphoma, Chronic Disease, +31 more
- Locations
-
Not specified
Not Yet Recruiting
Efficacy and Safety of TC011 in Relapsed or Refractory Follicular Lymphoma
NCT07360288
- Conditions
- Follicular Lymphoma (FL), Hemic and Lymphatic Diseases, Immune System Diseases, +8 more
- Locations
-
Not specified
Not Yet Recruiting
Efficacy and Safety of Zuberitamab Combined with Bendamustine, Followed by Monotherapy Maintenance, in Treatment-naïve Follicular Lymphoma
NCT06757894
- Conditions
- Follicular Lymphoma (FL), Hemic and Lymphatic Diseases, Immune System Diseases, +8 more
- Locations
-
- Sun Yat-sen Universitiy Cancer Center, Sun Yat-Sen University Guangzhou, Guangdong, China
Not Yet Recruiting
The Microbiome in Blood Cancer and HLH
NCT06734624
- Conditions
- Diffuse Large B Cell Lymphoma (DLBCL), Follicular Lymphoma (FL), Haemophagocytic Lymphohistiocytosis, +15 more
- Locations
-
- University of Nottingham Nottingham, Nottinghamshire, United Kingdom
Completed
ACP-196 (Acalabrutinib) in Combination With Pembrolizumab, for Treatment of Hematologic Malignancies
NCT02362035
- Conditions
- Blood Protein Disorders, Burkitt Lymphoma, CLL, +47 more
- Locations
-
- Research Site Tucson, Arizona, United States
- Research Site Los Angeles, California, United States
- Research Site Denver, Colorado, United States
- Research Site Washington D.C., District of Columbia, United States
NCT04488354
- Conditions
- Blood Protein Disorders, Burkitt Lymphoma, Cardiovascular Diseases, +47 more
- Locations
-
- City of Hope National Medical Center Duarte, California, United States
- University of California at San Diego San Diego, California, United States
- University of Chicago Chicago, Illinois, United States
- Masonic Cancer Center, University of Minnesota Minneapolis, Minnesota, United States
NCT02875548
- Conditions
- Adenoma, Advanced Solid Tumors, Diffuse Large B-Cell Lymphoma (DLBCL), +24 more
- Locations
-
- University of Arizona Cancer Center Tucson, Arizona, United States
- California Cancer Associates For Research And Excellence, cCARE Santa Fe, California, United States
- Hematology Oncology Associates of the Treasure Coast - Port St. Lucie Port Saint Lucie, Florida, United States
- Moffitt Tampa, Florida, United States
NCT04537715
- Conditions
- Adenoma, Advanced Malignancies, All Malignancies, +32 more
- Locations
-
- California Cancer Associates for Research and Excellence, Inc. (cCARE) Encinitas, California, United States
- The Angeles Clinic and Research Institute Los Angeles, California, United States
- Northwestern University-Robert H. Lurie Comprehensive Cancer Center Chicago, Illinois, United States
- South Texas Accelerated Research Therapeutics (START) Midwest Grand Rapids, Michigan, United States